IBM advances to Stage C of DARPA quantum benchmarking program for fault-tolerant systems
Bitget2026/10/07 21:30IBM advanced to Stage C of DARPA’s Quantum Benchmarking Initiative, moving into independent testing of its quantum hardware. Selection triggers verification work by DARPA’s IV&V team to assess IBM’s path to a fault-tolerant quantum computer. IBM reiterated its target to deliver its first fault-tolerant system in 2029, ahead of DARPA’s 2033 program goal. IBM cited progress on core fault-tolerance hardware components, supported by recent advances in efficient error-correction decoding. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. IBM - International Business Machines Corporation published the original content used to generate this news brief via PR Newswire (Ref. ID: 202610071730PR_NEWS_USPR_____NY66019) on October 07, 2026, and is solely responsible for the information contained therein.
- IBM advanced to Stage C of DARPA’s Quantum Benchmarking Initiative, moving into independent testing of its quantum hardware.
- Selection triggers verification work by DARPA’s IV&V team to assess IBM’s path to a fault-tolerant quantum computer.
- IBM reiterated its target to deliver its first fault-tolerant system in 2029, ahead of DARPA’s 2033 program goal.
- IBM cited progress on core fault-tolerance hardware components, supported by recent advances in efficient error-correction decoding.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Medifast updates financial calendar
Zurn Elkay Water Solutions publishes update to financial calendar
MannKind CEO to Join Chronic Respiratory Disease Panel at Chardan Healthcare Conference